The role of cerebral ischemia in Alzheimer's disease
- PMID: 10867217
- DOI: 10.1016/s0197-4580(00)00125-1
The role of cerebral ischemia in Alzheimer's disease
Abstract
The Alzheimer type of dementia and stroke are known to increase at comparable rates with age. Recent advances suggest that vascular risk factors linked to cerebrovascular disease and stroke in the elderly significantly increase the risk of developing Alzheimer's disease (AD). These include atherosclerosis, atrial fibrillation, coronary artery disease, hypertension, and diabetes mellitus. Moreover, review of various autopsy series shows that 60-90% of AD cases exhibit variable cerebrovascular pathology. Although some vascular lesions such as cerebral amyloid angiopathy, endothelial degeneration, and periventricular white matter lesions are evident in most cases of AD, a third will exhibit cerebral infarction. Despite the interpretation of pathological evidence, longitudinal clinical studies suggest that the co-existence of stroke and AD occurs more than by chance alone. Strokes known to occur in patients with Alzheimer syndrome and most frequently in the oldest old substantially worsen cognitive decline and outcome, implicating some interaction between the disorders. Nevertheless, the nature of a true relationship between the two disorders seems little explored. What predisposes to strokes in underlying cognitive decline or AD? Is it possible that cerebral ischemia is a causal factor for AD? I examined several vascular factors and the vascular pathophysiology implicated in stroke and AD, and propose that cerebral ischemia or oligemia may promote Alzheimer type of changes in the aging brain. Irrespective of the ultimate pathogenetic mechanism, these approaches implicate that management of peripheral vascular disease is important in the treatment or prevention of Alzheimer's disease or mixed dementia.
Similar articles
-
The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease.Ann N Y Acad Sci. 1999;893:113-25. doi: 10.1111/j.1749-6632.1999.tb07821.x. Ann N Y Acad Sci. 1999. PMID: 10672233 Review.
-
Vascular factors in Alzheimer's disease.Int Psychogeriatr. 2003;15 Suppl 1:47-52. doi: 10.1017/S1041610203008950. Int Psychogeriatr. 2003. PMID: 16191216
-
Alzheimer disease and cerebrovascular pathology: an update.J Neural Transm (Vienna). 2002 May;109(5-6):813-36. doi: 10.1007/s007020200068. J Neural Transm (Vienna). 2002. PMID: 12111471 Review.
-
Overlap between pathology of Alzheimer disease and vascular dementia.Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13 Suppl 3:S115-23. doi: 10.1097/00002093-199912003-00017. Alzheimer Dis Assoc Disord. 1999. PMID: 10609690 Review.
-
Small vessel disease and Alzheimer's dementia: pathological considerations.Cerebrovasc Dis. 2002;13 Suppl 2:48-52. doi: 10.1159/000049150. Cerebrovasc Dis. 2002. PMID: 11901243 Review.
Cited by
-
Caregiver coping strategies predict cognitive and functional decline in dementia: the Cache County Dementia Progression Study.Am J Geriatr Psychiatry. 2013 Jan;21(1):57-66. doi: 10.1016/j.jagp.2012.10.005. Epub 2013 Jan 2. Am J Geriatr Psychiatry. 2013. PMID: 23290203 Free PMC article.
-
Neuronal and vascular oxidative stress in Alzheimer's disease.Curr Neuropharmacol. 2011 Dec;9(4):662-73. doi: 10.2174/157015911798376244. Curr Neuropharmacol. 2011. PMID: 22654724 Free PMC article.
-
Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer's disease mouse models.Acta Neuropathol. 2013 Sep;126(3):353-64. doi: 10.1007/s00401-013-1145-2. Epub 2013 Jul 2. Acta Neuropathol. 2013. PMID: 23818064 Free PMC article.
-
Hypertension and cognitive function: pathophysiologic effects of hypertension on the brain.Curr Hypertens Rep. 2003 Jun;5(3):255-61. doi: 10.1007/s11906-003-0029-6. Curr Hypertens Rep. 2003. PMID: 12724059 Review.
-
Hydrogen sulfide as a neuromodulator.Mol Neurobiol. 2002 Aug;26(1):13-9. doi: 10.1385/MN:26:1:013. Mol Neurobiol. 2002. PMID: 12392053 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical